Related Experiment Video
Updated: Aug 13, 2025
05:46
Author Spotlight: Advancements in Refractive Surgical Correction for Presbyopia and Exploring Postoperative Visual Acuity
Published on: September 20, 2024
495
Pharmacological Treatments for Presbyopia
Betina Orman1, Giovanna Benozzi2
1Universidad de Buenos Aires, Facultad de Odontología, Cátedra de Farmacología, Buenos Aires, Argentina. betina.orman@odontologia.uba.ar.
Drugs & Aging
|January 20, 2023
Summary
Presbyopia, an age-related loss of eye focusing ability, can now be treated with new non-invasive eyedrops. These pharmacological treatments offer a promising alternative to glasses and surgery for improving near vision.
Area of Science:
- Ophthalmology
- Optometry
- Pharmacology
Background:
- Accommodation is the eye's ability to change focus for clear vision at all distances.
- Presbyopia, occurring with aging, is characterized by the loss of accommodation, impairing near vision.
- The triad of accommodation involves pupil size, lens shape/position, and ocular convergence, regulated by the parasympathetic nervous system.
Purpose of the Study:
- To provide an update on recent advances in pharmacological treatments for presbyopia.
- To review non-invasive topical eyedrop strategies for presbyopia management.
- To discuss the mechanisms and potential of novel presbyopia therapies.
Main Methods:
- Review of current pharmacological approaches for presbyopia treatment.
- Discussion of three main strategies: pinhole effect via miosis, binocular accommodation rehabilitation, and lens elasticity restoration with lipoic acid.
- Emphasis on topical, non-invasive eyedrop administration and patient selection.
Main Results:
- Pharmacological treatments represent a promising, non-invasive option for presbyopia.
- Three distinct pharmacological strategies are emerging, targeting different aspects of visual function.
- Reported adverse effects are minimal, highlighting the safety profile of these treatments.
Conclusions:
- Pharmacological interventions offer a new, safe, and effective avenue for managing presbyopia.
- Careful patient selection is crucial for optimizing outcomes with these novel treatments.
- Continued research and development in pharmacological presbyopia treatment are advancing visual rehabilitation.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
516
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
516
01:28Angle Closure Glaucoma: Treatment
608
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
608
01:16Focusing of Light in the Eye
3.0K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.0K
01:11Direct-Acting Cholinergic Agonists: Therapeutic Uses
821
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
821
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.5K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.5K
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
745
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
745